Since the last ECDC rapid risk assessment in 2021, the number of European Union/European Economic Area (EU/EEA) countries reporting cases of hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23 has increased from four to 10 countries, and the number of isolates submitted for analysis by these countries has increased from 12 to 143 isolates.